FLGT FY 2017 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$447M

FY 2017 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$19M+2.5% YoY

Gross Profit

$10M54.3% margin

Operating Income

-$3M-18.6% margin

Net Income

-$3M-13.4% margin

EPS (Diluted)

$-0.15

Cash Flow

Operating Cash Flow

$1M

Free Cash Flow

-$4M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$57M

Total Liabilities

$3M

Stockholders' Equity

$54M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19M	$18M	+2.5%
Gross Profit	$10M	$12M	-11.9%
Operating Income	-$3M	$919,000	-478.9%
Net Income	-$3M	-$5M	+53.1%